Inactive Instrument

ECHO THERAPEUTICS Stock OTC Bulletin Board

US27876L1070

Advanced Medical Equipment & Technology

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

22/03/17	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Chief Executive Officer	CI
23/11/16	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Interim Chief Executive Officer	CI

Latest news : ECHO THERAPEUTICS

22/03/17	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Chief Executive Officer	CI
23/11/16	Echo Therapeutics, Inc. Appoints Alan W. Schoenbart as Interim Chief Executive Officer	CI
27/09/16	Echo Therapeutics, Inc. Announces Resignation of Dr. Elazer Edelman as Member of the Board of Directors and Audit Committee	CI
12/08/16	Echo Therapeutics, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2016	CI
13/07/16	Echo Therapeutics, Inc.(OTCPK:ECTE) dropped from S&P TMI Index	CI
12/07/16	Echo Therapeutics, Inc. Primary Exchange Listing will Change to OTCQB Marketplace from Nasdaq Capital Market	CI
11/07/16	Echo Therapeutics, Inc.(NasdaqCM:ECTE) dropped from NASDAQ Composite Index	CI
13/06/16	Echo Therapeutics, Inc. Announces Institutional Review Board Approval of New Protocol	CI
10/06/16	Echo Therapeutics Seeks Acquisitions	CI
26/05/16	Echo Therapeutics, Inc. Announces New Appointments	CI
20/05/16	Echo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2016	CI
03/05/16	Echo Therapeutics, Inc. announced that it has received $4.47 million in funding.	CI
31/03/16	Echo Therapeutics, Inc. Reports Consolidated Earnings Results for the Year Ended December 31, 2015	CI

More news

Other Advanced Medical Equipment & Technology

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	-1.52%	+5.88%	+18.68%	-1.35%	213B
DANAHER CORPORATION	+0.25%	-5.44%	-4.97%	-25.29%	135B
INTUITIVE SURGICAL, INC.	+1.90%	-3.10%	-31.50%	+3.45%	117B
BOSTON SCIENTIFIC CORPORATION	+1.54%	-0.48%	-58.74%	-16.01%	64.78B
EDWARDS LIFESCIENCES CORPORATION	+3.65%	+1.30%	+14.57%	-4.98%	48.26B
SIEMENS HEALTHINEERS AG	+2.59%	-0.80%	-27.27%	-32.01%	43.08B
AGILENT TECHNOLOGIES, INC.	-0.92%	+5.42%	+15.16%	+8.51%	39.47B
WATERS CORPORATION	-1.58%	+2.49%	+26.70%	+31.77%	37.55B
ILLUMINA, INC.	-1.93%	+4.13%	+80.56%	+3.34%	29.78B
Average	+0.48%	-3.37%	+3.69%	-3.62%	80.91B
Weighted average by Cap.	+0.29%	-4.90%	-0.92%	-5.95%

See all sector performances

Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company